Relapsed or refractory diffuse large B cell lymphoma (DLBCL)

Clinical trials for Relapsed or refractory diffuse large B cell lymphoma (DLBCL) explained in plain language.

Never miss a new study

Get alerted when new Relapsed or refractory diffuse large B cell lymphoma (DLBCL) trials appear

Sign up with your email to follow new studies for Relapsed or refractory diffuse large B cell lymphoma (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a burst of radiation make CAR t-cells fight cancer harder?

Disease control Not yet recruiting

This trial tests whether adding a small dose of total body radiation to standard CAR T-cell therapy can help the immune cells grow stronger and last longer in the body. It enrolls adults with relapsed or hard-to-treat diffuse large B-cell lymphoma or multiple myeloma who are alre…

Matched conditions: RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)

Phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

Relapsed or refractory diffuse large B cell lymphoma (DLBCL)

Get alerted when new Relapsed or refractory diffuse large B cell lymphoma (DLBCL) trials appear

Can a burst of radiation make CAR t-cells fight cancer harder?